Acadia Pharmaceuticals in 2016 launched Nuplazid, which quells delusions associated with Parkinson’s disease. Acadia is among a small crop of San Diego drugmakers that self-commercialized, a counterpoint to the partnering norm. Photo courtesy of Acadia

Acadia Pharmaceuticals in 2016 launched Nuplazid, which quells delusions associated with Parkinson’s disease. Acadia is among a small crop of San Diego drugmakers that self-commercialized, a counterpoint to the partnering norm. Photo courtesy of Acadia

— Several San Diego biotechs — including Neurocrine and Arena Pharmaceuticals — are bucking the norm by handling drug commercialization themselves...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • NEW: San Diego 500 — influential business leaders you need to know
Yours for only $129